Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Journal of Behavioral Medicine 6/2016

27-02-2016

Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data

Auteurs: Stephen J. Tueller, Pascal R. Deboeck, Richard A. Van Dorn

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 6/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Medication adherence is thought to be the principal clinical predictor of positive clinical outcomes, not only for serious mental illnesses such as schizophrenia, bipolar disorder, or depression, but also for physical conditions such as diabetes. Consequently, research on medication often looks not only at medication condition (e.g., placebo, standard medication, investigative medication), but also at adherence in taking those medications within each medication condition. The percentage (or proportion) scale is one of the more frequently employed and easily interpretable measures. Patients can be 0 % adherent, 100 % adherent, or somewhere in between. For simplicity, many reported adherence analyses dichotomize or trichotomize the adherence predictor when estimating its effect on outcomes of interest. However, the methodological literature shows that the practice of categorizing continuously distributed predictors reduces statistical power at best and, at worst, can severely bias parameter estimates. This can result in inflated Type I errors (false positive acceptance of null adherence effects) or Type II errors (false negative rejection of true adherence effects). We extend the methodological literature on categorization to the construct of adherence. The measurement scale of adherence leads to a diverse family of potential distributions including uniform, n-shaped, u-shaped (i.e., bimodal), positively skewed, and negatively skewed. Using a simulation study, we generated negative, null, and positive “true” effects of adherence on simulated continuous and binary outcomes. We then estimated the adherence effect with and without categorizing the adherence variable. We show how parameter estimates and standard errors can be severely biased when categorizing adherence. The categorization of adherence is shown to cause null effects to become positive or negative depending on the distribution of the simulated adherence variable, inflating Type I errors. When the adherence effect was significantly different from zero, categorization can render the effect null, inflating Type II errors. We recommend that adherence be measured continuously and analyzed without categorization when using it as a predictor in regression models.
Literatuur
go back to reference Acosta, F. J., Ramallo-Fariña, Y., & Siris, S. G. (2014). Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment. Comprehensive Psychiatry, 55, 33–39. CrossRefPubMed Acosta, F. J., Ramallo-Fariña, Y., & Siris, S. G. (2014). Should full adherence be a necessary goal in schizophrenia? Full versus non-full adherence to antipsychotic treatment. Comprehensive Psychiatry, 55, 33–39. CrossRefPubMed
go back to reference Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., & Conley, R. R. (2010). The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry, 10, 2. CrossRefPubMedPubMedCentral Ascher-Svanum, H., Zhu, B., Faries, D. E., Salkever, D., Slade, E. P., Peng, X., & Conley, R. R. (2010). The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry, 10, 2. CrossRefPubMedPubMedCentral
go back to reference Asmundson, G. J., Taylor, S., Carleton, R. N., Weeks, J. W., & Hadjstavropoulos, H. D. (2012). Should health anxiety be carved at the joint? A look at the health anxiety construct using factor mixture modeling in a non-clinical sample. Journal of Anxiety Disorders, 26, 246–251. CrossRefPubMed Asmundson, G. J., Taylor, S., Carleton, R. N., Weeks, J. W., & Hadjstavropoulos, H. D. (2012). Should health anxiety be carved at the joint? A look at the health anxiety construct using factor mixture modeling in a non-clinical sample. Journal of Anxiety Disorders, 26, 246–251. CrossRefPubMed
go back to reference Buysman, E. K., Liu, F., Hammer, M., & Langer, J. (2015). Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: A retrospective cohort study. Advances in Therapy, 32, 341–355. CrossRefPubMedPubMedCentral Buysman, E. K., Liu, F., Hammer, M., & Langer, J. (2015). Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: A retrospective cohort study. Advances in Therapy, 32, 341–355. CrossRefPubMedPubMedCentral
go back to reference Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T., et al. (2005). A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research, 133, 129–133. CrossRefPubMed Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T., et al. (2005). A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Research, 133, 129–133. CrossRefPubMed
go back to reference Byerly, M. J., Nakonezny, P. A., & Rush, A. J. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 100, 60–69. CrossRefPubMed Byerly, M. J., Nakonezny, P. A., & Rush, A. J. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 100, 60–69. CrossRefPubMed
go back to reference Davis, J. M., Chen, N., & Glick, I. D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry, 60, 553–564. CrossRefPubMed Davis, J. M., Chen, N., & Glick, I. D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry, 60, 553–564. CrossRefPubMed
go back to reference DeCoster, J., Iselin, A. M. R., & Gallucci, M. (2009). A conceptual and empirical examination of justifications for dichotomization. Psychological Methods, 14, 349. CrossRefPubMed DeCoster, J., Iselin, A. M. R., & Gallucci, M. (2009). A conceptual and empirical examination of justifications for dichotomization. Psychological Methods, 14, 349. CrossRefPubMed
go back to reference Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Van Dorn, R. (2005). Medication nonadherence and substance abuse in psychotic disorders: Impact of depressive symptoms and social stability. The Journal of Nervous and Mental Disease, 193, 673–679. CrossRefPubMed Elbogen, E. B., Swanson, J. W., Swartz, M. S., & Van Dorn, R. (2005). Medication nonadherence and substance abuse in psychotic disorders: Impact of depressive symptoms and social stability. The Journal of Nervous and Mental Disease, 193, 673–679. CrossRefPubMed
go back to reference Fedorov, V., Mannino, F., & Zhang, R. (2009). Consequences of dichotomization. Pharmaceutical Statistics, 8, 50–61. CrossRefPubMed Fedorov, V., Mannino, F., & Zhang, R. (2009). Consequences of dichotomization. Pharmaceutical Statistics, 8, 50–61. CrossRefPubMed
go back to reference Ferguson, N. M., Donnelly, C. A., Hooper, J., Ghani, A. C., Fraser, C., Bartley, L. M., et al. (2005). Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. Journal of the Royal Society, Interface, 2, 349–363. CrossRefPubMedPubMedCentral Ferguson, N. M., Donnelly, C. A., Hooper, J., Ghani, A. C., Fraser, C., Bartley, L. M., et al. (2005). Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. Journal of the Royal Society, Interface, 2, 349–363. CrossRefPubMedPubMedCentral
go back to reference Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004). Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692–699. CrossRefPubMed Gilmer, T. P., Dolder, C. R., Lacro, J. P., Folsom, D. P., Lindamer, L., Garcia, P., & Jeste, D. V. (2004). Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry, 161, 692–699. CrossRefPubMed
go back to reference Hepke, K. L., Martus, M. T., & Share, D. A. (2004). Costs and utilization associated with pharmaceutical adherence in a diabetic population. The American Journal of Managed Care, 10, 144–151. PubMed Hepke, K. L., Martus, M. T., & Share, D. A. (2004). Costs and utilization associated with pharmaceutical adherence in a diabetic population. The American Journal of Managed Care, 10, 144–151. PubMed
go back to reference Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., et al. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126, 529–537. CrossRefPubMed Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., et al. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126, 529–537. CrossRefPubMed
go back to reference Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119, 3028–3035. CrossRefPubMed Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119, 3028–3035. CrossRefPubMed
go back to reference Hommel, K. A., Davis, C. M., & Baldassano, R. N. (2008). Medication adherence and quality of life in pediatric inflammatory bowel disease. Journal of Pediatric Psychology, 33, 867–874. CrossRefPubMedPubMedCentral Hommel, K. A., Davis, C. M., & Baldassano, R. N. (2008). Medication adherence and quality of life in pediatric inflammatory bowel disease. Journal of Pediatric Psychology, 33, 867–874. CrossRefPubMedPubMedCentral
go back to reference Ibrahim, A. R., Eliasson, L., Apperley, J. F., Milojkovic, D., Bua, M., Szydlo, R., et al. (2011). Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood, 117, 3733–3736. CrossRefPubMed Ibrahim, A. R., Eliasson, L., Apperley, J. F., Milojkovic, D., Bua, M., Szydlo, R., et al. (2011). Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood, 117, 3733–3736. CrossRefPubMed
go back to reference Ivanova, J. I., Bergman, R. E., Birnbaum, H. G., Phillips, A. L., Stewart, M., & Meletiche, D. M. (2012). Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US. Journal of Medical Economics, 15, 601–609. CrossRefPubMed Ivanova, J. I., Bergman, R. E., Birnbaum, H. G., Phillips, A. L., Stewart, M., & Meletiche, D. M. (2012). Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US. Journal of Medical Economics, 15, 601–609. CrossRefPubMed
go back to reference Juarez, D. T., Tan, C., Davis, J., & Mau, M. (2013). Factors affecting sustained medication adherence and its impact on healthcare utilization in patients with diabetes. Journal of Pharmaceutical Health Services Research, 4, 89–94. CrossRefPubMedPubMedCentral Juarez, D. T., Tan, C., Davis, J., & Mau, M. (2013). Factors affecting sustained medication adherence and its impact on healthcare utilization in patients with diabetes. Journal of Pharmaceutical Health Services Research, 4, 89–94. CrossRefPubMedPubMedCentral
go back to reference Knapp, M., King, D., Pugner, K., & Lapuerta, P. (2004). Non-adherence to antipsychotic medication regimens: Associations with resource use and costs. The British Journal of Psychiatry, 184, 509–516. CrossRefPubMed Knapp, M., King, D., Pugner, K., & Lapuerta, P. (2004). Non-adherence to antipsychotic medication regimens: Associations with resource use and costs. The British Journal of Psychiatry, 184, 509–516. CrossRefPubMed
go back to reference Lilienfeld, S. O. (2014). DSM-5: Centripetal scientific and centrifugal antiscientific forces. Clinical Psychology: Science and Practice, 21, 269–279. Lilienfeld, S. O. (2014). DSM-5: Centripetal scientific and centrifugal antiscientific forces. Clinical Psychology: Science and Practice, 21, 269–279.
go back to reference Lubke, G. H., & Miller, P. J. (2015). Does nature have joints worth carving? A discussion of taxometrics, model-based clustering and latent variable mixture modeling. Psychological Medicine, 45, 705–715. CrossRefPubMed Lubke, G. H., & Miller, P. J. (2015). Does nature have joints worth carving? A discussion of taxometrics, model-based clustering and latent variable mixture modeling. Psychological Medicine, 45, 705–715. CrossRefPubMed
go back to reference Lubke, G., & Tueller, S. (2010). Latent class detection and class assignment: A comparison of the MAXEIG taxometric procedure and factor mixture modeling approaches. Structural Equation Modeling, 17, 605–628. CrossRefPubMedPubMedCentral Lubke, G., & Tueller, S. (2010). Latent class detection and class assignment: A comparison of the MAXEIG taxometric procedure and factor mixture modeling approaches. Structural Equation Modeling, 17, 605–628. CrossRefPubMedPubMedCentral
go back to reference MacCallum, R. C., Zhang, S., Preacher, K. J., & Rucker, D. D. (2002). On the practice of dichotomization of quantitative variables. Psychological Methods, 7, 19. CrossRefPubMed MacCallum, R. C., Zhang, S., Preacher, K. J., & Rucker, D. D. (2002). On the practice of dichotomization of quantitative variables. Psychological Methods, 7, 19. CrossRefPubMed
go back to reference Maggiolo, F., Airoldi, M., Kleinloog, H. D., Callegaro, A., Ravasio, V., Arici, C., et al. (2007). Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV Clinical Trials, 8, 282–292. CrossRefPubMed Maggiolo, F., Airoldi, M., Kleinloog, H. D., Callegaro, A., Ravasio, V., Arici, C., et al. (2007). Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients. HIV Clinical Trials, 8, 282–292. CrossRefPubMed
go back to reference McFadden, D. (1974). Conditional logit analysis of qualitative choice behavior. In P. Zarembka (Ed.), Frontiers in econometrics (pp. 105–142). New York, NY: Academic Press. McFadden, D. (1974). Conditional logit analysis of qualitative choice behavior. In P. Zarembka (Ed.), Frontiers in econometrics (pp. 105–142). New York, NY: Academic Press.
go back to reference Menard, S. (2000). Coefficients of determination for multiple logistic regression analysis. The American Statistician, 54, 17–24. Menard, S. (2000). Coefficients of determination for multiple logistic regression analysis. The American Statistician, 54, 17–24.
go back to reference Nakonezny, P. A., Byerly, M. J., & Rush, A. J. (2008). Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity. Psychiatry Research, 157, 259–263. CrossRefPubMed Nakonezny, P. A., Byerly, M. J., & Rush, A. J. (2008). Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: An empirical evaluation of its reliability and predictive validity. Psychiatry Research, 157, 259–263. CrossRefPubMed
go back to reference Nichols, G. A., Rosales, A. G., Kimes, T. M., Tunceli, K., Kurtyka, K., Mavros, P., & Steiner, J. F. (2015). Impact on glycated haemoglobin of a biological response-based measure of medication adherence. Diabetes, Obesity & Metabolism, 17, 843–848. doi: 10.​1111/​dom.​12476 CrossRef Nichols, G. A., Rosales, A. G., Kimes, T. M., Tunceli, K., Kurtyka, K., Mavros, P., & Steiner, J. F. (2015). Impact on glycated haemoglobin of a biological response-based measure of medication adherence. Diabetes, Obesity & Metabolism, 17, 843–848. doi: 10.​1111/​dom.​12476 CrossRef
go back to reference Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2014). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51, 216–222. CrossRef Olfson, M., Mechanic, D., Hansell, S., Boyer, C. A., Walkup, J., & Weiden, P. J. (2014). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services, 51, 216–222. CrossRef
go back to reference Onyebuchi, A. K., Lawani, L. O., Iyoke, C. A., Onoh, C. R., & Okeke, N. E. (2014). Adherence to intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine and outcome of pregnancy among parturients in South East Nigeria. Patient Preference and Adherence, 8, 447–452. doi: 10.​2147/​PPA.​S61448 PubMedPubMedCentral Onyebuchi, A. K., Lawani, L. O., Iyoke, C. A., Onoh, C. R., & Okeke, N. E. (2014). Adherence to intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine and outcome of pregnancy among parturients in South East Nigeria. Patient Preference and Adherence, 8, 447–452. doi: 10.​2147/​PPA.​S61448 PubMedPubMedCentral
go back to reference Pringle, J. L., Boyer, A., Conklin, M. H., McCullough, J. W., & Aldridge, A. (2014). The Pennsylvania Project: Pharmacist intervention improved medication adherence and reduced health care costs. Health Affairs, 33, 1444–1452. CrossRefPubMed Pringle, J. L., Boyer, A., Conklin, M. H., McCullough, J. W., & Aldridge, A. (2014). The Pennsylvania Project: Pharmacist intervention improved medication adherence and reduced health care costs. Health Affairs, 33, 1444–1452. CrossRefPubMed
go back to reference Remington, G., Kwon, J., Collins, A., Laporte, D., Mann, S., & Christensen, B. (2007). The use of electronic monitoring (MEMS ®) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research, 90, 229–237. CrossRefPubMed Remington, G., Kwon, J., Collins, A., Laporte, D., Mann, S., & Christensen, B. (2007). The use of electronic monitoring (MEMS ®) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research, 90, 229–237. CrossRefPubMed
go back to reference Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011). Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs, 30, 91–99. CrossRefPubMed Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011). Medication adherence leads to lower health care use and costs despite increased drug spending. Health Affairs, 30, 91–99. CrossRefPubMed
go back to reference Shentu, Y., & Xie, M. (2010). A note on dichotomization of continuous response variable in the presence of contamination and model misspecification. Statistics in Medicine, 29, 2200–2214. CrossRefPubMed Shentu, Y., & Xie, M. (2010). A note on dichotomization of continuous response variable in the presence of contamination and model misspecification. Statistics in Medicine, 29, 2200–2214. CrossRefPubMed
go back to reference Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43, 521–530. CrossRefPubMed Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and healthcare cost. Medical Care, 43, 521–530. CrossRefPubMed
go back to reference Sun, S. X., Liu, G. G., Christensen, D. B., & Fu, A. Z. (2007). Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Current Medical Research and Opinion, 23, 2305–2312. doi: 10.​1185/​030079907X226050​ CrossRefPubMed Sun, S. X., Liu, G. G., Christensen, D. B., & Fu, A. Z. (2007). Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States. Current Medical Research and Opinion, 23, 2305–2312. doi: 10.​1185/​030079907X226050​ CrossRefPubMed
go back to reference Svarstad, B., Shireman, T., & Sweeney, J. (2001). Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services, 52, 805–811. CrossRefPubMed Svarstad, B., Shireman, T., & Sweeney, J. (2001). Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatric Services, 52, 805–811. CrossRefPubMed
go back to reference Swanson, J. W., Swartz, M. S., Van Dorn, R. A., Elbogen, E. B., Wagner, H. R., Rosenheck, R. A., et al. (2006). A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry, 63, 490–499. CrossRefPubMed Swanson, J. W., Swartz, M. S., Van Dorn, R. A., Elbogen, E. B., Wagner, H. R., Rosenheck, R. A., et al. (2006). A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry, 63, 490–499. CrossRefPubMed
go back to reference Swanson, J. W., Swartz, M. S., Van Dorn, R. A., Volavka, J., Monahan, J., Stroup, T. S., et al. (2008). Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. The British Journal of Psychiatry, 193, 37–43. CrossRefPubMedPubMedCentral Swanson, J. W., Swartz, M. S., Van Dorn, R. A., Volavka, J., Monahan, J., Stroup, T. S., et al. (2008). Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. The British Journal of Psychiatry, 193, 37–43. CrossRefPubMedPubMedCentral
go back to reference Swanson, J., Van Dorn, R. A., & Swartz, M. S. (2007). Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. Schizophrenia Research, 94, 114–118. CrossRefPubMed Swanson, J., Van Dorn, R. A., & Swartz, M. S. (2007). Effectiveness of atypical antipsychotics for substance use in schizophrenia patients. Schizophrenia Research, 94, 114–118. CrossRefPubMed
go back to reference Swartz, M. S., Swanson, J. W., Hiday, V. A., Borum, R., Wagner, H. R., & Burns, B. J. (1998a). Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. American Journal of Psychiatry, 155, 226–231. PubMed Swartz, M. S., Swanson, J. W., Hiday, V. A., Borum, R., Wagner, H. R., & Burns, B. J. (1998a). Violence and severe mental illness: The effects of substance abuse and nonadherence to medication. American Journal of Psychiatry, 155, 226–231. PubMed
go back to reference Swartz, M. S., Swanson, J. W., Hiday, V. A., Borum, R., Wagner, R., & Burns, B. J. (1998b). Taking the wrong drugs: The role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33, S75–S80. CrossRefPubMed Swartz, M. S., Swanson, J. W., Hiday, V. A., Borum, R., Wagner, R., & Burns, B. J. (1998b). Taking the wrong drugs: The role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33, S75–S80. CrossRefPubMed
go back to reference Valenstein, M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., et al. (2002). Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40, 630–639. CrossRefPubMed Valenstein, M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., et al. (2002). Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care, 40, 630–639. CrossRefPubMed
go back to reference Valenstein, M., Ganoczy, D., McCarthy, J. F., Myra, K. H., Lee, T. A., & Blow, F. C. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. The Journal of Clinical Psychiatry, 67, 1542–1550. CrossRefPubMed Valenstein, M., Ganoczy, D., McCarthy, J. F., Myra, K. H., Lee, T. A., & Blow, F. C. (2006). Antipsychotic adherence over time among patients receiving treatment for schizophrenia: A retrospective review. The Journal of Clinical Psychiatry, 67, 1542–1550. CrossRefPubMed
go back to reference Van Dorn, R. A., Desmarais, S. L., Petrila, J., Haynes, D., & Singh, J. P. (2013). Effects of outpatient treatment on risk of arrest of adults with serious mental illness and associated costs. Psychiatric Services, 64, 856–862. CrossRefPubMed Van Dorn, R. A., Desmarais, S. L., Petrila, J., Haynes, D., & Singh, J. P. (2013). Effects of outpatient treatment on risk of arrest of adults with serious mental illness and associated costs. Psychiatric Services, 64, 856–862. CrossRefPubMed
go back to reference Vestbo, J., Anderson, J. A., Calverley, P. M., Celli, B., Ferguson, G. T., Jenkins, C., et al. (2009). Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939–943. CrossRefPubMed Vestbo, J., Anderson, J. A., Calverley, P. M., Celli, B., Ferguson, G. T., Jenkins, C., et al. (2009). Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939–943. CrossRefPubMed
go back to reference Wei, L., Fahey, T., & MacDonald, T. M. (2008). Adherence to statin or aspirin or both in patients with established cardiovascular disease: Exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. British Journal of Clinical Pharmacology, 66, 110–116. CrossRefPubMedPubMedCentral Wei, L., Fahey, T., & MacDonald, T. M. (2008). Adherence to statin or aspirin or both in patients with established cardiovascular disease: Exploring healthy behaviour vs. drug effects and 10-year follow-up of outcome. British Journal of Clinical Pharmacology, 66, 110–116. CrossRefPubMedPubMedCentral
go back to reference Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services, 55, 886–891. CrossRefPubMed Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services, 55, 886–891. CrossRefPubMed
go back to reference Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350 × 109 cells/L. Annals of Internal Medicine, 139, 810–816. CrossRefPubMed Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350 × 109 cells/L. Annals of Internal Medicine, 139, 810–816. CrossRefPubMed
go back to reference Yasuda, J. M., Miller, C., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., et al. (2004). The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antiviral Therapy, 9, 753–762. PubMed Yasuda, J. M., Miller, C., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., et al. (2004). The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antiviral Therapy, 9, 753–762. PubMed
go back to reference Yen, C. F., Chen, C. S., Ko, C. H., Yeh, M. L., Yang, S. J., Yen, J. Y., et al. (2005). Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study. Psychiatry and Clinical Neurosciences, 59, 403–409. CrossRefPubMed Yen, C. F., Chen, C. S., Ko, C. H., Yeh, M. L., Yang, S. J., Yen, J. Y., et al. (2005). Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study. Psychiatry and Clinical Neurosciences, 59, 403–409. CrossRefPubMed
Metagegevens
Titel
Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data
Auteurs
Stephen J. Tueller
Pascal R. Deboeck
Richard A. Van Dorn
Publicatiedatum
27-02-2016
Uitgeverij
Springer US
Gepubliceerd in
Journal of Behavioral Medicine / Uitgave 6/2016
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI
https://doi.org/10.1007/s10865-016-9727-9